Tesamorelin

Tesamorelin is engineered from the GHRH sequence with stabilising modifications that extend its activity relative to the native hormone, making it a more practical tool for studying the GHRH–growth-hormone axis. Where native GHRH degrades quickly, tesamorelin's modified backbone gives researchers a longer, more reproducible window of receptor engagement.

Much of the research literature places tesamorelin within metabolic and lipid contexts, particularly the study of visceral adipose tissue, because of the growth-hormone axis's connection to lipid handling. That positions it close to the metabolic cluster alongside Reta Labs' flagship work.

Compared with direct growth-hormone tools or fragments, tesamorelin's interest lies upstream — at the level of the releasing-hormone receptor — which is why investigators select it when the research question concerns the regulatory axis rather than the hormone's terminal effects.

• GHRH-Axis Signalling — Tesamorelin is studied for its agonism at the GHRH receptor and the resulting modulation of growth-hormone release in models.
• Lipid Metabolism Research — The literature examines its association with visceral adipose-tissue metabolism.
• Metabolic Research — It appears in study panels investigating growth-hormone-axis contributions to metabolism.
• Comparative Endocrine Studies — It serves as an upstream tool relative to direct growth-hormone compounds.

• Retatrutide — Reta Labs' flagship metabolic research peptide.
• MOTS-c — A mitochondrial-derived peptide within the metabolic research domain.
• HGH Fragment 176-191 — A growth-hormone fragment studied in lipid-metabolism research.

Where can I buy tesamorelin in Canada for research?

Tesamorelin is supplied to Canadian research buyers as a lyophilized, research-grade peptide, HPLC-verified to ≥99% with MS-confirmed identity and a batch-specific COA.

How is tesamorelin different from HGH Fragment 176-191?

Tesamorelin acts upstream as a GHRH-receptor agonist influencing growth-hormone release, while HGH Fragment 176-191 is a terminal fragment of growth hormone studied for lipid-metabolism activity directly.

Is tesamorelin naturally occurring?

It is a synthetic, stabilised analogue of the natural hormone GHRH, modified for improved research stability rather than isolated from a natural source.

How are purity and identity verified?

Each batch is HPLC-verified (≥99%) and MS-confirmed, with a batch-specific COA. Material is lyophilized and stored at 2–8 °C, protected from light.

⚠️ For research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.